Feasibility of Specimen Self-collection in Young Children Undergoing SARS-CoV-2 Surveillance for In-Person Learning대면 학습을 위해 SARS-CoV-2 감시를 받는 어린 아동의 표본 자체 수집 가능성Research Published on 2022-02-172022-09-12 Journal: JAMA Network Open [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI African Asian black Can children cohort study collected conducted Consent Course COVID-19 Data collection decrease demographic data enrolled error error rate evidenced feasibility finding highest Importance learning measure median multiracial nasal swab nasal swabs objective occurred Older option parameter participant Participants Point Quantitative data Relevance Research Result sample collection SARS-CoV-2 SARS-CoV-2 surveillance SARS-CoV-2 testing scalability School setting specimen specimen collection student Surveillance surveillance testing Swab Testing waiver [DOI] 10.1001/jamanetworkopen.2021.48988 PMC 바로가기 [Article Type] Research
Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global DemandPlant Science Published on 2022-02-072022-10-31 Journal: Frontiers in Plant Science [Category] COVID-19, [키워드] Activation anti-SARS-CoV-2 ART Artemisia annua Artemisinin boost cancers clinical study combating compounds COVID-19 COVID-19 pandemic Demand derivatives different disease Effect effective human ACE2 human cells IKK Increased Inflammation Interaction interfere Like malaria NF-κB signaling option pathway positive receptors SARS-CoV-2 SARS-COV-2 infection sesquiterpene lactone Symptom these compound transcriptional activity Treatment viral endocytosis viral infections viral spike protein [DOI] 10.3389/fpls.2022.780257 PMC 바로가기 [Article Type] Plant Science
The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling study저소득 및 중간 소득 국가를 위한 의약품의 지적 재산권 라이선스가 경제 및 공중 보건에 미치는 영향: 모델링 연구Article Published on 2022-02-012022-09-11 Journal: The Lancet. Public Health [Category] COVID19(2023년), SARS, 치료제, [키워드] absence arising assumption benefit chain country COVID-19 pandemic cumulative cumulative effect daclatasvir death dolutegravir downstream Effect Effects estimate faster HCV Health hepatitis C hepatitis C virus HIV leads Medicine Medicines option outcome outcomes Patent Patent Pool patients treated pool predicted Primary outcome Primary outcomes public health Quantitative reduction Research robust suggested Supply chain These data upstream Volume [DOI] 10.1016/S2468-2667(21)00202-4 PMC 바로가기 [Article Type] Article
“LONG COVID”-A hypothesis for understanding the biological basis and pharmacological treatment strategy"LONG COVID"-생물학적 기초 및 약리학적 치료 전략 이해를 위한 가설Review Published on 2022-02-012022-09-11 Journal: Pharmacology Research & Perspectives [Category] COVID19(2023년), MERS, SARS, 바이오마커, 신약개발, 치료제, [키워드] “LONG COVID”. ACE-2 activate activator antioxidant Asymptomatic battery binding biological basis blood vessel blood vessels cause clinical study clinical trial Cohort cough COVID-19 cytokine Depression diagnosed disease drug elevated eliminated Endothelial cell endothelial cells Endothelium enzyme Enzymes evaluate expression fatigue free radical Free radicals glutathione Human Hypothesis hypoxia Inflammation Insomnia longitudinal Loss of Smell loss of smell and/or taste marker melatonin non-infected normal activity Nrf2 nuclear option oxidative oxidative stress oxygen Pain pathology pharmacological treatment proportion Protein reactive oxygen species replicate Replication required Safe SARS-CoV-2 SARS-CoV-2 virus severe pneumonia Shortness of breath subject subjects Symptom Symptoms syndrome Tachycardia Taste these cell These cells tissue tissue hypoxia transcription factor variety Viral viral replication virus were infected [DOI] 10.1002/prp2.911 PMC 바로가기 [Article Type] Review
Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccinesResearch article Published on 2022-02-012022-10-05 Journal: Medical Hypotheses [Category] 변종, [키워드] Adenoviridae Adenovirus affected antibody binding caused Coagulation complex COVID-19 vaccines described DNA Factor X healthcare immune response Immunity Impaired impairment individuals mechanism Mutation offer option Platelet platelet activation PROTECT Protein stimulate thrombocytopenia thromboembolic complication Thromboembolic event thrombotic event Vaccine Vaccines Venous thrombosis virus [DOI] 10.1016/j.mehy.2021.110756 [Article Type] Research article
Convenience Food Options and Adequacy of Nutrient Intake among School Children during the COVID-19 PandemicArticle Published on 2022-01-312022-10-30 Journal: Nutrients [Category] Coronavirus, SARS, [키워드] Adequacy association caused changes in children collected convenience convenience food COVID-19 COVID-19 pandemic defined Diet quality examined food Frequency Habitual help information intake Japan Japanese no significant difference nutrient nutrition nutritional intake nutritional status option participant questionnaire resulting risk School school children significantly higher sociodemographic factors take-out food was collected [DOI] 10.3390/nu14030630 PMC 바로가기 [Article Type] Article
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives중간엽 줄기세포 기반 COVID-19 치료: 생명공학적 관점Review Published on 2022-01-292022-09-11 Journal: Cells [Category] 변종, [키워드] ACE2 acute lung injury acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 bioengineering cause clinical trial clinics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 therapy genetic engineering Infection Inflammatory diseases Lung injury mesenchymal stem cell Mesenchymal stem cells MSC MSCs offer option pathogenic Perspective pulmonary diseases respiratory respiratory distress SARS-CoV-2 SARS-COV-2 infection STEM syndrome the SARS-CoV-2 therapeutic efficacy therapeutic option therapeutic options therapy TMPRSS2 Treatment variant [DOI] 10.3390/cells11030465 PMC 바로가기 [Article Type] Review
Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic Infections원생동물 및 기생충 기생충 감염 환자의 코로나19 이전 혈청 중 S 및 N 단백질에 대한 SARS-CoV-2 항체 검출 분석의 특이성Article Published on 2022-01-192022-09-11 Journal: Journal of Clinical Microbiology [Category] MERS, SARS, 진단, 치료기술, [키워드] 95% CI Abbott Abbott SARS-CoV-2 IgG acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 African trypanosomiasis anti-SARS-CoV-2 IgG antibody Antibody detection Antibody test Architect clinically suspected collected coronavirus COVID-19 detection diagnostic Diagnostic accuracy diagnostic test estimate Evidence evidence of false false-positive result False-positive results filaria helminth helminth infections holoendemic IgG IgM IgM/IgG indicated Infection infections kinetoplastid infections majority malaria neglected tropical diseases Neutralization antibody option parasitic infections past Patient Patient care positive protozoan infection protozoan infections provide Rapid diagnostic test RDT required respiratory reticuloendothelial system SARS-CoV-2 SARS-CoV-2 neutralization Schistosoma sera Serological assay serological assays serology seropositive severe acute respiratory syndrome Coronavirus specificity specimen Standard Q Strongyloides tested threshold Trichinella tropical trypanosomiasis visceral leishmaniasis [DOI] 10.1128/JCM.01717-21 PMC 바로가기 [Article Type] Article
Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency사례 시리즈: COVID-19 및 1차 항체 결핍 환자를 위한 회복기 혈장 요법Original Article Published on 2021-12-102022-09-12 Journal: Journal of Clinical Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] antibody appear applied benefit Clinical symptoms Cohort common variable immunodeficiency convalescent plasma convalescent plasma treatment country Course COVID-19 COVID19 patient deficiency demonstrated Effectiveness Evidence Fever Follow-up Hypogammaglobulinemia immunocompromised individual immunocompromised individuals inborn errors of immunity Infection longitudinal many case many cases monoclonal antibody Mutation one patient option Patient PCR plasma primary antibody Primary immunodeficiencies reduction in resolved risk Safe SARS-CoV-2 Sequencing Side effect supplementary material Therapeutic benefit Therapies treated Treatment viral genome Viral load Viral RNA shedding viral shedding while with COVID-19 [DOI] 10.1007/s10875-021-01193-2 PMC 바로가기 [Article Type] Original Article
Pharmacological Treatment Options for Coronavirus Disease-19 in Renal PatientsReview Article Published on 2021-11-302022-10-29 Journal: International Journal of Nephrology [Category] COVID-19, [키워드] Antiviral Chronic kidney disease CKD clinical trial COVID-19 database determine dialysis dosage drug drug combination Efficacy Experimental drugs global pandemic greater high-risk patient infected with COVID-19 information kidney dysfunction management MONITOR monoclonal antibody notable option patients performed preexisting comorbidities renal renal damage renal function required risk SARS-CoV-2 Side effect Side effects Stage therapeutic effect Treatment [DOI] 10.1155/2021/4078713 PMC 바로가기 [Article Type] Review Article